Edwards Lifesciences Corp. (EW) Tops Q4 EPS by 9c

February 3, 2014 4:09 PM

Edwards Lifesciences Corp. (NYSE: EW) reported Q4 EPS of $0.91, $0.09 better than the analyst estimate of $0.82. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found